Open-Label Extension Safety Study of PROCRIT in Patients With Anemia of Chronic Disease Due to Rheumatoid Arthritis
Status:
Withdrawn
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety profile of epoetin alfa in
patients with anemia of chronic disease due to rheumatoid arthritis